论文部分内容阅读
目的:观察瑞舒伐他汀和替米沙坦对原发性高血压(EH)并发阵发性心房纤颤(AF)患者心电图P波时限和离散度及AF发生率的影响。方法:EH并发阵发性AF患者56例,随机分为2组:替米沙坦(80 mg/d)加瑞舒伐他汀(10 mg/d)组(联合用药组)和替米沙坦(80 mg/d)组。共观察6个月。分别于用药前后测定12导联体表心电图中P波的时限和P波离散度及AF发生率。结果:用药后两组均可使EH并发阵发性EH患者心电图P波的时限和P波离散度减小,组间比较显示,联合用药组的作用优于单用替米沙坦组。结论:瑞舒伐他汀合用替米沙坦对EH并发阵发性AF患者窦律的维持及预防AF发生的作用优于单用替米沙坦。
Objective: To observe the effects of rosuvastatin and telmisartan on the electrocardiographic P wave duration and dispersion and the incidence of AF in patients with essential hypertension (EH) complicated with paroxysmal atrial fibrillation (AF). Methods: Fifty-six patients with EH concurrent paroxysmal AF were randomly divided into 2 groups: telmisartan (80 mg / d) and rosuvastatin (10 mg / d) (combination group) and telmisartan (80 mg / d) group. A total of 6 months observation. Respectively before and after treatment measured 12 lead surface ECG P wave duration and P wave dispersion and AF incidence. Results: After treatment, EH patients with paroxysmal EH complicated with P wave duration and P wave dispersion could be reduced in both groups. The comparison among groups showed that the combination group was superior to telmisartan alone. Conclusion: The effect of rosuvastatin combined with telmisartan on the maintenance of sinus rhythm and prevention of AF in patients with EH complicated with paroxysmal AF is better than telmisartan alone.